Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 90 EP72 | DOI: 10.1530/endoabs.90.EP72

Charles Nicolles Hospital, Endocrinology Department, Tunis, Tunisia


Introduction: Pheochromocytomas are rare catecholamine-secreting tumors presenting with various clinical manifestations. Hypertension is the most common finding in pheochromocytomas. It can be either persistent or paroxysmal. Study Design: We conducted a retrospective study of 34 patients who were admitted into the endocrinology department of Charles Nicolle hospital, with a diagnosis of a pheochromocytoma from January 2005 to November 2022.

Results: Twenty one patients (64%) had a family history of hypertension. Nine patients (27%) had diabetes and eight patients (25%) had dyslipidemia. Twenty six patients (77%) had hypertension. The median of years with hypertension was 3.5 years IQR (1-5,7). The mean number of used antihypertensive drugs was 2.4 ±1.3 [extremes:1-6]. Two patients had coronary disease and one patient had heart failure. An ultrasound myocardium imaging was practiced in 22 patients. Myocardial amyotrophy was detected in 36% of cases (eight patients). Five patients had electric EKG abnormalities. Hypertensive retinopathy, microalbuminuria and chronic kidney disease were detected in 18, 93 and 20% of cases, respectively. Surgical treatment was performed in 27 cases (93%). Fifteen (56%) patients were cured of their hypertension after surgery.

Conclusions: Pheochromocytomas are considered as one of the most common causes of curable hypertension. Early diagnosis of theses tumors is important, owing the possibility of curing hypertension and preventing its lethal complications.

Volume 90

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.